Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Expert Opinion on Drug Safety|December 3, 2010
The expanding role of nilotinib in chronic myeloid leukemiaTheo Daniel Kim, Philipp le CoutreBiomarker Insights|September 25, 2015
Emerging Role of Tyrosine Kinases as Drugable Targets in CancerIl-Kang Na, Philipp le CoutreActa Haematologica|May 26, 2023
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular AnalysisThomas Burmeister, Lars Bullinger, Philipp le CoutreClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemiaPhilipp le Coutre, Michaela Schwarz, Theo D KimExpert Review of Hematology|November 19, 2010
Nilotinib for the treatment of chronic myeloid leukemiaTheo Daniel Kim, Bernd Dörken, Philipp le CoutreRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
NilotinibMartin Gresse, Theo D Kim, Philipp le CoutreExpert Opinion on Pharmacotherapy|September 16, 2011
Omacetaxine mepesuccinate for the treatment of leukemiaTheo Daniel Kim, Mareike Frick, Philipp le CoutreFuture Oncology (London, England)|December 14, 2019
The role of bosutinib in the treatment of chronic myeloid leukemiaCarlo Gambacorti-Passerini, Philipp le Coutre, Rocco PiazzaScientific Reports|October 3, 2019
HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cellsLydon Wainaina Nyambura, Alejandro Azorin Muñoz, Philipp le Coutre, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2010
NilotinibAlfonso Quintás-Cardama, Theo Daniel Kim, Vince Cataldo, et al.Pageof 11